newsfilter
← Latest News
PR Newswire·

Leap Therapeutics Announces $40 Million Private Placement

Leap Therapeutics, Inc. (Nasdaq:LPTX), a biotechnology company focused on developing targeted and immuno-oncology therapeutics, today announced it...